Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 6 | 2013 | 1136 | 1.020 |
Why?
|
| Tissue Banks | 2 | 2011 | 29 | 0.430 |
Why?
|
| Tissue Donors | 3 | 2012 | 502 | 0.410 |
Why?
|
| Water-Electrolyte Balance | 1 | 2014 | 81 | 0.400 |
Why?
|
| Hypernatremia | 1 | 2014 | 32 | 0.400 |
Why?
|
| Hyponatremia | 1 | 2014 | 72 | 0.390 |
Why?
|
| Sodium | 1 | 2014 | 280 | 0.380 |
Why?
|
| Caroli Disease | 1 | 2012 | 2 | 0.370 |
Why?
|
| Liver Failure | 1 | 2013 | 100 | 0.360 |
Why?
|
| Donor Selection | 1 | 2012 | 58 | 0.350 |
Why?
|
| Death | 1 | 2012 | 78 | 0.340 |
Why?
|
| Brain Death | 1 | 2012 | 74 | 0.340 |
Why?
|
| Precision Medicine | 2 | 2011 | 381 | 0.340 |
Why?
|
| Seasons | 1 | 2012 | 333 | 0.330 |
Why?
|
| Cystic Fibrosis | 1 | 2013 | 266 | 0.320 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 324 | 0.290 |
Why?
|
| Patient Selection | 1 | 2011 | 721 | 0.270 |
Why?
|
| Genome, Human | 2 | 2011 | 1322 | 0.270 |
Why?
|
| Databases, Factual | 1 | 2012 | 1223 | 0.260 |
Why?
|
| Graft Survival | 3 | 2013 | 461 | 0.240 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2011 | 1005 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2012 | 1076 | 0.220 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 1395 | 0.200 |
Why?
|
| Internship and Residency | 1 | 2012 | 1215 | 0.180 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 669 | 0.180 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3112 | 0.160 |
Why?
|
| Databases, Nucleic Acid | 2 | 2011 | 72 | 0.110 |
Why?
|
| Incidence | 2 | 2012 | 3330 | 0.100 |
Why?
|
| Aspergillus fumigatus | 1 | 2013 | 43 | 0.100 |
Why?
|
| Forecasting | 2 | 2011 | 353 | 0.100 |
Why?
|
| Aspergillosis | 1 | 2013 | 46 | 0.100 |
Why?
|
| Schools, Medical | 1 | 2013 | 113 | 0.090 |
Why?
|
| Deltaretrovirus Infections | 1 | 2011 | 7 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 1399 | 0.090 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2012 | 58 | 0.090 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 41 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 602 | 0.090 |
Why?
|
| Living Donors | 1 | 2011 | 112 | 0.080 |
Why?
|
| Epigenomics | 1 | 2011 | 182 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 200 | 0.080 |
Why?
|
| End Stage Liver Disease | 1 | 2012 | 193 | 0.080 |
Why?
|
| Waiting Lists | 1 | 2011 | 242 | 0.080 |
Why?
|
| Humans | 9 | 2014 | 130422 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2011 | 221 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 1 | 2012 | 253 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1377 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2011 | 507 | 0.070 |
Why?
|
| Sepsis | 1 | 2013 | 494 | 0.070 |
Why?
|
| Body Weight | 1 | 2012 | 984 | 0.070 |
Why?
|
| Disease Progression | 2 | 2011 | 2205 | 0.070 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 802 | 0.070 |
Why?
|
| Child | 3 | 2013 | 26165 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2011 | 388 | 0.070 |
Why?
|
| Survival Rate | 1 | 2012 | 2131 | 0.060 |
Why?
|
| Male | 5 | 2013 | 64527 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2013 | 12860 | 0.060 |
Why?
|
| Exome | 1 | 2011 | 1075 | 0.060 |
Why?
|
| Female | 5 | 2013 | 70285 | 0.060 |
Why?
|
| Prevalence | 1 | 2011 | 2685 | 0.050 |
Why?
|
| Texas | 1 | 2013 | 3626 | 0.050 |
Why?
|
| Adolescent | 2 | 2013 | 20754 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1838 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 2024 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6190 | 0.050 |
Why?
|
| United States | 3 | 2012 | 11827 | 0.050 |
Why?
|
| Middle Aged | 2 | 2012 | 28383 | 0.040 |
Why?
|
| Adult | 2 | 2012 | 31127 | 0.040 |
Why?
|
| Infant | 2 | 2012 | 13269 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2012 | 14985 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2012 | 17614 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 131 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 222 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 628 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 1276 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 910 | 0.010 |
Why?
|
| Liver | 1 | 2011 | 1797 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3425 | 0.010 |
Why?
|